• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA-A*31:01 与不同类型卡马西平诱导的严重皮肤不良反应:一项国际研究和荟萃分析。

HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis.

机构信息

Inserm U946, Saint Louis Hospital, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.

1] Department of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan [2] Department of Medical Biotechnology and Laboratory Science, Chang Gung University College of Medicine, Taoyuan, Taiwan.

出版信息

Pharmacogenomics J. 2014 Jun;14(3):281-8. doi: 10.1038/tpj.2013.40. Epub 2013 Dec 10.

DOI:10.1038/tpj.2013.40
PMID:24322785
Abstract

HLA-A31:01 was reported to be associated with carbamazepine (CBZ)-induced severe cutaneous adverse reactions (SCAR), including drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). We conducted an international study using consensus diagnosis criteria to enroll a total of 93 patients with CBZ-SCAR from Europe or Asia. We found that HLA-A31:01 showed a significant association with CBZ-DRESS in Europeans (P<0.001; odds ratio (OR) (95% confidence interval (CI))=57.6 (11.0-340)), and the strong association was also found in Chinese (P<0.001; OR (95% CI)=23.0 (4.2-125)). However, HLA-A31:01 had no association with CBZ-SJS/TEN in neither Chinese nor Europeans. By comparison, HLA-B15:02 showed a strong association with CBZ-SJS/TEN in Chinese (P<0.001, OR (95% CI)=58.1 (17.6-192)). A meta-analysis of this and other published studies confirmed that in all populations, HLA-A31:01 had an extremely strong association with CBZ-DRESS (P<0.001, a pooled OR (95% CI)=13.2 (8.4-20.8)), but a much weaker association with CBZ-SJS/TEN (P=0.01, OR (95% CI)=3.94 (1.4-11.5)). Our data revealed that HLA-A31:01 is a specific predictor for CBZ-DRESS but not for CBZ-SJS/TEN. More studies are needed to investigate the genetic determinant of CBZ-SJS/TEN in Europeans. Considering the potential clinical utility, the cost-effectiveness of the combined HLA-A31:01 and HLA-B15:02 genetic test to prevent CBZ-SCAR in Chinese needs further investigation.

摘要

HLA-A31:01 与卡马西平(CBZ)诱导的严重皮肤不良反应(SCAR)有关,包括药物反应伴嗜酸性粒细胞增多和全身症状(DRESS)、史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)。我们采用共识诊断标准进行了一项国际研究,共纳入来自欧洲或亚洲的 93 例 CBZ-SCAR 患者。我们发现 HLA-A31:01 与欧洲人 CBZ-DRESS 显著相关(P<0.001;比值比(OR)(95%置信区间(CI))=57.6(11.0-340)),在中国人群中也发现了强烈的相关性(P<0.001;OR(95% CI)=23.0(4.2-125))。然而,HLA-A31:01 与中、欧人群的 CBZ-SJS/TEN 均无关。相比之下,HLA-B15:02 与中国人 CBZ-SJS/TEN 显著相关(P<0.001,OR(95% CI)=58.1(17.6-192))。对这项研究和其他已发表研究的荟萃分析证实,在所有人群中,HLA-A31:01 与 CBZ-DRESS 具有极强的相关性(P<0.001,合并 OR(95% CI)=13.2(8.4-20.8)),但与 CBZ-SJS/TEN 的相关性较弱(P=0.01,OR(95% CI)=3.94(1.4-11.5))。我们的数据表明,HLA-A31:01 是 CBZ-DRESS 的特异性预测因子,但不是 CBZ-SJS/TEN 的预测因子。需要进一步研究欧洲人 CBZ-SJS/TEN 的遗传决定因素。鉴于其潜在的临床应用价值,需要进一步研究在中国人群中联合 HLA-A31:01 和 HLA-B15:02 基因检测预防 CBZ-SCAR 的成本效益。

相似文献

1
HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis.HLA-A*31:01 与不同类型卡马西平诱导的严重皮肤不良反应:一项国际研究和荟萃分析。
Pharmacogenomics J. 2014 Jun;14(3):281-8. doi: 10.1038/tpj.2013.40. Epub 2013 Dec 10.
2
Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.HLA 与卡马西平诱导的过敏反应的基因型-表型关联:强度和临床相关性。
J Dermatol Sci. 2014 Feb;73(2):101-9. doi: 10.1016/j.jdermsci.2013.10.003. Epub 2013 Oct 22.
3
A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions.卡马西平致严重药物不良反应的斑贴试验和交叉过敏研究。
J Eur Acad Dermatol Venereol. 2013 Mar;27(3):356-64. doi: 10.1111/j.1468-3083.2011.04418.x. Epub 2012 Jan 3.
4
HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.HLA-B*1502 强烈预测了卡马西平诱导的泰国民众神经痛患者的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症。
Pain Pract. 2012 Mar;12(3):202-8. doi: 10.1111/j.1533-2500.2011.00479.x. Epub 2011 Jun 16.
5
Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.泰国 HLA-B*15:02 筛查在卡马西平引起的严重药物不良反应中的经济评估。
Epilepsia. 2013 Sep;54(9):1628-38. doi: 10.1111/epi.12325. Epub 2013 Jul 29.
6
Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.建议进行 HLA-B*15:02 和 HLA-A*31:01 基因检测,以降低卡马西平诱导的过敏反应风险。
Epilepsia. 2014 Apr;55(4):496-506. doi: 10.1111/epi.12564. Epub 2014 Mar 5.
7
Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population.与芳香族抗癫痫药物(AED)诱导的中毒性表皮坏死松解症(SJS/TEN)显著相关的HLA I类类型与西班牙人群中相同AED诱导的药物反应伴嗜酸性粒细胞增多和系统症状(DRESS)所发现的不同。
Pharmacol Res. 2017 Jan;115:168-178. doi: 10.1016/j.phrs.2016.11.027. Epub 2016 Nov 22.
8
Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.马来亚多民族人群中 HLA-B*1502 等位基因与卡马西平诱导的中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征的关联。
Int J Dermatol. 2011 Feb;50(2):221-4. doi: 10.1111/j.1365-4632.2010.04745.x.
9
Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine.与卡马西平引起的严重皮肤不良反应相关的遗传变异。
Br J Clin Pharmacol. 2022 Feb;88(2):773-786. doi: 10.1111/bcp.15022. Epub 2021 Aug 28.
10
The HLA-B*15:02 polymorphism and Tegretol-induced serious cutaneous reactions in epilepsy: An updated systematic review and meta-analysis.HLA-B*15:02 多态性与泰瑞替尼引起的癫痫严重皮肤反应:更新的系统评价和荟萃分析。
Rev Neurol (Paris). 2018 May;174(5):278-291. doi: 10.1016/j.neurol.2017.11.006.

引用本文的文献

1
Drug hypersensitivity reactions in children in clinical practice: A WAO Statement.临床实践中儿童药物过敏反应:世界过敏组织声明
World Allergy Organ J. 2025 Aug 29;18(9):101087. doi: 10.1016/j.waojou.2025.101087. eCollection 2025 Sep.
2
Clinical manifestations, diagnostic criteria, and treatment outcomes of minocycline-associated DRESS syndrome: a comprehensive exploration of published cases.米诺环素相关的药物超敏反应伴嗜酸性粒细胞增多和系统症状(DRESS)综合征的临床表现、诊断标准及治疗结果:已发表病例的综合探究
Front Pharmacol. 2025 Jul 22;16:1515000. doi: 10.3389/fphar.2025.1515000. eCollection 2025.
3
Clinical diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in children: An EAACI position paper.
儿童药物超敏反应伴嗜酸性粒细胞增多和全身症状(DRESS)的临床诊断与管理:欧洲变态反应和临床免疫学会立场文件
Pediatr Allergy Immunol. 2025 Jul;36(7):e70103. doi: 10.1111/pai.70103.
4
The association between the number of HLA risk alleles and drug allergy and its implications for HLA screening - a case-control study.HLA风险等位基因数量与药物过敏之间的关联及其对HLA筛查的意义——一项病例对照研究。
Pharmacogenomics J. 2025 Feb 18;25(2):1. doi: 10.1038/s41397-025-00362-5.
5
Pharmacogenomics predictors of aromatic antiepileptic drugs-induced SCARs in the Iraqi patients.伊拉克患者中芳香族抗癫痫药物所致严重皮肤不良反应的药物基因组学预测指标
Heliyon. 2024 Dec 18;11(1):e41108. doi: 10.1016/j.heliyon.2024.e41108. eCollection 2025 Jan 15.
6
Viral reactivation and clinical outcomes in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).药物反应伴嗜酸性粒细胞增多和全身性症状(DRESS)中的病毒再激活与临床结局。
Sci Rep. 2024 Nov 18;14(1):28492. doi: 10.1038/s41598-024-69054-7.
7
Phenomic landscape and pharmacogenomic implications for HLA region in a Taiwan Han Chinese population.台湾汉族人群中HLA区域的表型图谱及药物基因组学意义
Biomark Res. 2024 May 3;12(1):46. doi: 10.1186/s40364-024-00591-z.
8
Severe cutaneous adverse reactions.严重皮肤不良反应。
Nat Rev Dis Primers. 2024 Apr 25;10(1):30. doi: 10.1038/s41572-024-00514-0.
9
Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.奥卡西平诱发的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的临床特征分析
Front Med (Lausanne). 2023 Oct 10;10:1232969. doi: 10.3389/fmed.2023.1232969. eCollection 2023.
10
Genotypic and Phenotypic Characteristics of Co-Trimoxazole-Induced Cutaneous Adverse Reactions.复方新诺明诱导的皮肤不良反应的表型和基因型特征。
Dermatology. 2023;239(6):966-975. doi: 10.1159/000534342. Epub 2023 Oct 4.